Analysts’ Perspective: Virtusa (VRTU), Iovance Biotherapeutics (IOVA), Seagate Technology (STX)

Investment Analysts at Needham upgraded Virtusa Corp. (NASDAQ:VRTU) shares from Buy to Strong Buy rating with a price target of $65.

Virtusa Corp. engages in the provision of information technology consulting, technology implementation, and application outsourcing services.


Brokerage Firm B. Riley FBR, Inc. upgraded Iovance Biotherapeutics Inc. (NASDAQ:IOVA) shares from Neutral to Buy rating with a price target of $22.

Iovance Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on the development of cancer immunotherapy products for the treatment of various cancers.


Seagate Technology PLC (NASDAQ:STX) shares were upgraded by analysts at Morgan Stanley from Equal-Weight to Overweight rating wirth a price target $72.

Seagate Technology Plc engages in the development, production, and distribution of data storage products and electronic data storage solutions.


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at